NDC properties for "temazepam 22.5 MG Oral Capsule" (RxCUI 485489)
About this data
The tables show NDC propoerties for temazepam 22.5 MG Oral Capsule with the RxCUI 485489
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for temazepam 22.5 MG Oral Capsule (RxCUI 485489)
| ANDA | ANDA071457 |
|---|---|
| ANDA | ANDA201781 |
| ANDA | ANDA203482 |
| ANDA | ANDA211542 |
| MMSL_CODE | BD13300 |
| MMSL_CODE | CD13300 |
| NDA | NDA018163 |
| RxCUI | 485489 |
| SNOMEDCT | 430273009 |
| SPL_SET_ID | 1e37d59b-b8be-46ef-8706-fffd563a8c15 |
| SPL_SET_ID | 3ce42f0e-821e-4c9a-8f6b-60621628fd4b |
| SPL_SET_ID | 74a3db09-94d0-45e1-8c68-da7ca49d3d59 |
| SPL_SET_ID | 7e9c51d4-032b-48ab-9c19-6050d1e86512 |
| SPL_SET_ID | 85327378-86a3-4448-9185-e20bb20ebf45 |
| SPL_SET_ID | 8f54731f-c5b7-492c-acb0-444c5fbb7029 |
| SPL_SET_ID | 93b1be7f-ec41-46bb-a258-56cb459e2c92 |
| SPL_SET_ID | bcfd6a3d-66eb-4844-bede-6ec671985b2c |
| SPL_SET_ID | be68c6e0-17ad-40fe-9bc1-58abe24b53f6 |
| SPL_SET_ID | c9bc61b4-a579-4003-98da-b6f6e381c150 |
| SPL_SET_ID | dadc2f66-7fa5-4be4-a9d0-d96e5836f550 |
| SPL_SET_ID | db839409-8e95-41d3-804e-dcd5d11f4934 |
| SPL_SET_ID | dbea1ee6-cdaa-4b1a-8dd5-4bff31b2a1ef |
| SPL_SET_ID | f1ff672d-0b95-4e1b-9104-a545e02f4ee7 |
| VUID | 4025744 |
| Prescribable Synonym | temazepam 22.5 MG Oral Capsule |
| RXNAV_STR | temazepam 22.5 MG Oral Capsule |
| RxNorm Name | temazepam 22.5 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 485489) |
NDC Properties
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |
NDC Item 00378312093
| NDC 9 | 0378-3120 |
|---|---|
| NDC 10 | 0378-3120-93 |
| NDC Item | 00378312093 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-3120-93) |
| ANDA | ANDA070920 |
| COLORTEXT | YELLOW(yellow opaque),ORANGE(peach opaque) |
| Color | C48330;C48331 __ |
| DCSA | CIV |
| FDA SPL set id | 411913 |
| Imprint code | MYLAN;3120 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-10-31 |
| Marketing effective time low | 2009-06-15 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0378-3120 |
NDC Item 00406995903
| NDC 9 | 0406-9959 |
|---|---|
| NDC 10 | 0406-9959-03 |
| NDC Item | 00406995903 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 786605 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | SpecGx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-02-23 |
| Marketing status | ACTIVE |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0406-9959 |
NDC Item 35356082130
| NDC 9 | 35356-821 |
|---|---|
| NDC 10 | 35356-821-30 |
| NDC Item | 35356082130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763028 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Lake Erie Medical DBA: Quality Care Products LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 35356-821 |
NDC Item 43547061303
| NDC 9 | 43547-613 |
|---|---|
| NDC 10 | 43547-613-03 |
| NDC Item | 43547061303 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) |
| ANDA | ANDA201781 |
| COLORTEXT | BLUE(Opaque Blue) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 812831 |
| Imprint code | 22;5mg;S613 |
| Labeler | Solco Healthcare U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-05 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 43547-613 |
NDC Item 46708038130
| NDC 9 | 46708-381 |
|---|---|
| NDC 10 | 46708-381-30 |
| NDC Item | 46708038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (46708-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 690537 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 46708-381 |
NDC Item 50436463001
| NDC 9 | 50436-4630 |
|---|---|
| NDC 10 | 50436-4630-1 |
| NDC Item | 50436463001 |
| Packaging | 30 CAPSULE in 1 BOTTLE (50436-4630-1) |
| ANDA | ANDA071457 |
| COLORTEXT | blue(light blue opaque cap),white(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 260509 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Unit Dose Services |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 50436-4630 |
NDC Item 53489065007
| NDC 9 | 53489-650 |
|---|---|
| NDC 10 | 53489-650-07 |
| NDC Item | 53489065007 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (53489-650-07) |
| ANDA | ANDA071175 |
| COLORTEXT | white(opaque),green(light green opaque) |
| Color | C48325;C48329 __ |
| DCSA | CIV |
| FDA SPL set id | 399603 |
| Imprint code | Mutual;868 |
| Labeler | Sun Pharmaceutical Industries Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-10-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 53489-650 |
NDC Item 60760095930
| NDC 9 | 60760-959 |
|---|---|
| NDC 10 | 60760-959-30 |
| NDC Item | 60760095930 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (60760-959-30) |
| COLORTEXT | blue |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 428380 |
| Imprint code | FOR;SLEEP;M;22;5;mg |
| Labeler | St. Mary's Medical Park Pharmacy |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-10-24 |
| Marketing status | COMPLETED |
| NDA | NDA018163 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 60760-959 |
NDC Item 62332038130
| NDC 9 | 62332-381 |
|---|---|
| NDC 10 | 62332-381-30 |
| NDC Item | 62332038130 |
| Packaging | 30 CAPSULE in 1 BOTTLE (62332-381-30) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 707869 |
| Imprint code | A224 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 62332-381 |
NDC Item 63629860401
| NDC 9 | 63629-8604 |
|---|---|
| NDC 10 | 63629-8604-1 |
| NDC Item | 63629860401 |
| Packaging | 30 CAPSULE in 1 BOTTLE (63629-8604-1) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 763276 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 63629-8604 |
NDC Item 65162058403
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-03 |
| NDC Item | 65162058403 |
| Packaging | 30 CAPSULE in 1 BOTTLE (65162-584-03) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058410
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-10 |
| NDC Item | 65162058410 |
| Packaging | 100 CAPSULE in 1 BOTTLE (65162-584-10) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058411
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-11 |
| NDC Item | 65162058411 |
| Packaging | 1000 CAPSULE in 1 BOTTLE (65162-584-11) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 65162058450
| NDC 9 | 65162-584 |
|---|---|
| NDC 10 | 65162-584-50 |
| NDC Item | 65162058450 |
| Packaging | 500 CAPSULE in 1 BOTTLE (65162-584-50) |
| ANDA | ANDA203482 |
| COLORTEXT | white(OPAQUE BODY),pink(DARK PINK OPAQUE) |
| Color | C48325;C48328 __ |
| DCSA | CIV |
| FDA SPL set id | 824881 |
| Imprint code | AMNEAL;584 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-05-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 65162-584 |
NDC Item 67877014901
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-01 |
| NDC Item | 67877014901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67877-149-01) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014905
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-05 |
| NDC Item | 67877014905 |
| Packaging | 500 CAPSULE in 1 BOTTLE (67877-149-05) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 67877014930
| NDC 9 | 67877-149 |
|---|---|
| NDC 10 | 67877-149-30 |
| NDC Item | 67877014930 |
| Packaging | 30 CAPSULE in 1 BOTTLE (67877-149-30) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 757749 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67877-149 |
NDC Item 71335204301
| NDC 9 | 71335-2043 |
|---|---|
| NDC 10 | 71335-2043-1 |
| NDC Item | 71335204301 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2043-1) |
| ANDA | ANDA211542 |
| COLORTEXT | BLUE(opaque blue cap opaque blue body) |
| Color | C48333 __ |
| DCSA | CIV |
| FDA SPL set id | 748413 |
| Imprint code | A224 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 71335-2043 |
NDC Item 72162182703
| NDC 9 | 72162-1827 |
|---|---|
| NDC 10 | 72162-1827-3 |
| NDC Item | 72162182703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (72162-1827-3) |
| ANDA | ANDA071457 |
| COLORTEXT | BLUE(blue opaque cap),WHITE(white opaque body) |
| Color | C48333;C48325 __ |
| DCSA | CIV |
| FDA SPL set id | 774627 |
| Imprint code | 22;5mg;Novel122 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-06-28 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 72162-1827 |